Pfizer sees Q1 profits fall by almost a fifth

US drug maker Pfizer posted first-quarter profits down 19%, mainly because new generic competition to its blockbuster cholesterol pill Lipitor cut US sales by 15%.

The competition prompted the company to offer big rebates and discounts to keep patients on its brand.